Lab-grown “reductionist replicas” of the human brain are helping scientists understand fetal development and cognitive disorders, including autism. But ethical questions loom.
Tag: Clinical Trials
In Fight Against Malaria, an Unexpected — and Snuggly — Shield
Treating baby wraps with a mosquito repellent shows promising protection against a top killer of children.
Major Study on Transgender Youth Health Care to Begin in U.K.
Researchers at King’s College London will track the experiences of up to 3,000 children and teenagers who are being treated by Britain’s health service.
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
Promise of Victory Over H.I.V. Fades as U.S. Withdraws Support
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of the funding for that effort is gone.
South Africa Built a Medical Research Powerhouse. Trump Cuts Have Demolished It.
The budget cuts threaten global progress on everything from heart disease to H.I.V. — and could affect American drug companies, too.
Dozens of Clinical Trials Have Been Frozen in Response to Trump’s USAID Order
The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their bodies, with no access to monitoring or care.
Health Programs Shutter Around the World After Trump Pauses Foreign Aid
Lifesaving treatment and prevention programs for tuberculosis, malaria, H.I.V. and other diseases cannot access funds to continue work.
Health Programs Shutter Around the World After Trump Pauses Foreign Aid
Lifesaving treatment and prevention programs for tuberculosis, malaria, H.I.V. and other diseases cannot access funds to continue work.